Suberic Acid

Most of the fat your body burns gets broken down inside tiny power plants in your cells called mitochondria. When that main route is overloaded, blocked, or simply not keeping up, your liver switches on a backup pathway that produces a family of small organic acids you then pee out. Suberic acid is one of them.

Checking urinary suberic acid gives you a window into how heavily your body is leaning on that backup system. It is an exploratory marker rather than a routine screening test, but rising or unusually low levels can flag a problem with how you are processing fats that standard cholesterol or glucose panels will not detect.

What This Molecule Actually Is

Suberic acid, also called octanedioic acid, belongs to a group of small acids with two acid groups on opposite ends of the molecule, called dicarboxylic acids. It is made from fatty acids by a family of enzymes called CYP4F and CYP4A, which sit mainly in the liver. When mitochondrial fat burning falls behind, more fatty acids get diverted to these enzymes, more dicarboxylic acids get produced, and more of them end up in your urine.

Because the kidney clears these acids efficiently, urine concentrates the signal in a way blood does not. That is why organic acid testing in urine has been the standard approach for decades.

Inherited Fatty Acid Oxidation Disorders

The most established use of urinary suberic acid is in the diagnosis and monitoring of inherited disorders that block mitochondrial fat burning. In conditions like medium-chain acyl-CoA dehydrogenase deficiency (a genetic defect that blocks the breakdown of medium-length fats), suberic acid and other dicarboxylic acids climb sharply in urine, especially when the person has been fasting or sick. Patients with this condition show a disproportionate rise in urinary dicarboxylic acids compared to healthy people.

Similar patterns appear in other inherited fat-processing defects. In peroxisomal diseases like Zellweger syndrome and neonatal adrenoleukodystrophy, urinary dicarboxylic acids of medium and long chain lengths show up in excess and serve as a useful marker for these conditions. In a four-thousand-sample study of children, the ratio of one related dicarboxylic acid to a ketone (adipic acid to 3-hydroxybutyrate) was used as a prognostic indicator for fatty acid oxidation disorders, with ratios above 0.5 flagging a real problem.

What this means for you: even if you do not have a known genetic disorder, persistently high urinary suberic on multiple samples, especially when paired with low ketones, can hint that your mitochondrial fat handling is not keeping up with demand. That is worth investigating rather than ignoring.

Emerging Links Beyond Inherited Disease

Research is starting to connect dicarboxylic acids in urine to conditions that affect adults. In a study of 31 adult head and neck cancer patients receiving cisplatin chemotherapy, suberate in urine was one of several metabolites identified as an early predictive biomarker of cisplatin-induced acute kidney injury, appearing before standard kidney markers shifted.

Urinary dicarboxylic acids have also been linked to early Alzheimer's disease. A study examining urine in people without dementia symptoms found that changes in dicarboxylic acid patterns reflected loss of brain energy capacity and shrinking of the hippocampus, with the pattern showing 82 percent ability to correctly identify cognitively healthy individuals based on their cerebrospinal fluid amyloid and tau profile.

Evidence from research on plasma rather than urine adds another angle. In a study of about 100 pregnant women, lower plasma suberic acid (a related but different measurement than the urinary test) tracked with a buildup of fatty acids and was statistically linked to higher risk of preterm birth. Whether the same pattern shows up in urine has not been directly tested.

Why This Is a Phenotype Marker, Not a Simple High-Is-Bad Reading

Suberic acid behaves differently from a typical cholesterol or glucose number, where higher is worse in a straightforward way. It rises when your body is dumping fat through the backup pathway, which can mean either a real metabolic problem or simply that you ate a lot of medium-chain fats this week, were fasting, or were running on ketones. It can also drop in situations where fatty acids are accumulating in blood but not being converted to dicarboxylic acids efficiently. The number is best understood as a phenotype indicator that tells you what mode your fat metabolism is running in, not as a single good-bad threshold.

When Results Can Be Misleading

More than most markers, urinary suberic acid is sensitive to what you ate and how recently you ate it. The same number can mean very different things depending on context.

• Medium-chain triglyceride (MCT) intake: feeding MCT oil or coconut-derived fats raises urinary dicarboxylic acids substantially. The rise mimics inherited fat-processing disorders on a lab report but reflects diet, not disease. Specific ratios of saturated to unsaturated dicarboxylic acids help distinguish the two.
• Recent fasting or ketogenic eating: prolonged fasting and very-low-carb diets shift fat burning toward pathways that increase urinary dicarboxylic acid output. This is a normal adaptation, not a sign of disease, but it can produce a misleading result if your test is interpreted without diet context.
• Acute illness with poor intake: vomiting, infection, or any acute illness that interrupts eating can push your metabolism into a fasting-like state and temporarily raise suberic. Testing during illness is rarely informative.
• Lab method differences: organic acid analysis is mostly qualitative, and performance varies across laboratories. Two labs can report the same sample differently.

Tracking Your Trend

A single urinary suberic measurement is a snapshot of metabolism in the hours before collection. Because diet, fasting state, and exercise can swing the number, one reading should never drive a decision on its own. The useful signal comes from a stable pattern across repeated samples collected under similar conditions, such as a typical morning urine after a normal dinner.

Get a baseline, then retest in 3 to 6 months if you are changing your diet (especially toward keto, MCT, or coconut-heavy eating), starting carnitine or B-vitamin supplementation, or have a clinical reason to monitor fat metabolism. Annual rechecks are reasonable for general tracking. If a result is unexpectedly high or low, repeat the test under standardized conditions before treating it as real.

Decision Pathway for Unexpected Results

An out-of-pattern suberic reading is a starting point, not a diagnosis. The next step is to look at it in context with companion markers and a clear picture of what you have been eating.

• Pair it with other dicarboxylic acids and ketones: adipic and sebacic acids on the same panel help confirm that the pattern is real, and ketones like 3-hydroxybutyrate help separate diet-driven rises from metabolic dysfunction.
• Recheck under standardized conditions: repeat the urine collection after at least 24 hours without MCT oil, coconut oil, ketogenic eating, or prolonged fasting. If the elevation persists, it is more likely meaningful.
• Layer in mitochondrial and acylcarnitine markers: if multiple urine collections show persistently elevated dicarboxylic acids, an acylcarnitine profile (a blood test that identifies specific blocks in fat burning) is the standard next step.
• Consider specialist involvement when patterns persist: a metabolic or biochemical genetics specialist is the right partner if multiple samples and acylcarnitines together point to an inherited or acquired fat-processing problem.

The reader takeaway: this is an exploratory window into fat metabolism that gains value when tracked alongside its sister markers and interpreted with diet context, not in isolation.